NCT02041936View on ClinicalTrials.gov

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System

NAActive, not recruitingINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Unresectable Pancreatic Cancer

Interventions

DEVICE

NanoKnife IRE System

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER